Type of Cancer
Multiple Myeloma
Phase
Division (Location)
Study ID
NCT#
Brief Description
An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO®) In Combination with lenalodimide and Dexamethasone (IRD) in Patients with multiple Myeloma Previously Receiving a Bortozomib-Based Triplet Induction Regimen (TOURMALINE US MM-6)
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.